Science Strategic Acquisition Corp. Alpha

Science Strategic Acquisition Corp. Alpha

SSAA
Science Strategic Acquisition Corp. AlphaUS flagNASDAQ Capital Market
10.05
USD
-0.01
- -
Science Strategic Acquisition Corp. Alpha
SSAA
(NASDAQ Capital Market)

Recent

price

10.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Science Strategic Acquisition Corp. Alpha (SSAA) operates as a blank check company focused on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting direct-to-consumer (D2C) brands and services; mobile and social entertainment sectors. Incorporated in 2020 and headquartered in Santa Monica, California, the company maintains no significant ongoing operations and holds capital raised through its initial public offering for deployment in a strategic transaction. It features a seasoned management team led by Chairman and CEO Michael Jones and President Peter Pham, both founders of Science Inc., supported by directors including Greg Gilman, Tom Dare, Priscilla Guevara, and April Henry, who bring expertise in scaling D2C ventures, digital assets, and operational growth. As of late 2025, SSAA reports no completed mergers, acquisitions, or de-SPAC transactions, with recent activities centered on trust extensions and regulatory compliance amid a broader SPAC market rebound featuring over 100 new IPOs this year; the company sustains a market capitalization around $390 million, zero revenue, and minimal net income from operations.